A multi-histology trial of fostamatinib in patients with advanced colorectal, non-small cell lung, head and neck, thyroid, and renal cell carcinomas, and pheochromocytomas

PURPOSE: A multi-cohort phase II study of fostamatinib, an oral multi-kinase inhibitor, was conducted to determine the response rate in patients with advanced colorectal (CRC), thyroid, non-small-cell lung, head and neck, and renal cell carcinomas, and pheochromocytomas. METHODS: Patients received 2...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Chemother Pharmacol
Main Authors: Park, Sook Ryun, Speranza, Giovanna, Piekarz, Richard, Wright, John J., Kinders, Robert J., Wang, Lihua, Pfister, Thomas D., Trepel, Jane B., Lee, Min-Jung, Alarcon, Sylvia, Steinberg, Seth M., Collins, Jerry, Doroshow, James H., Kummar, Shivaani
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4457312/
https://ncbi.nlm.nih.gov/pubmed/23404627
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2091-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados